Coming Soon: Important OCE/IVE Updates
OCE and IVE sheets will soon be known as Patient Education Sheets — clearer, more consistent, and still rooted in the expert-backed information you rely on.
Advancements in Patient-Centered Care
Stay up to date with the latest advancements in oral oncolytics, medically-integrated oncology, and cancer care best practices.
NCODA UPDATES
Announcing the NCODA-ASCO Updated Standards for Medically Integrated Dispensing
NCODA, in collaboration with the American Society of Clinical Oncology (ASCO), is proud to announce updated Medically Integrated Dispensing (MID) standards. These revised standards expand the focus beyond medication dispensing to embrace a full spectrum of care — integrating patient-centered approaches addressing access, improving operational workflows, and optimizing outcomes.
NCODA Announces “Oncology Optimized Limited Distribution” to Bring Clarity and Enhance Patient-Centered Cancer Care Delivery
May 14, 2025
Cazenovia, New York, May 14, 2025 – During the recent NCODA International Spring Forum, the organization announced the formal definition of Oncology Optimized Limited Distribution (OOLD) to bring clarity to the broadly used term “limited distribution networks “(LDNs), within the oncology ecosystem. This effort supports the improved delivery of oral oncolytics and enhances patient outcomes by promoting medically integrated pharmacy models whenever possible.
NCODA 2025 International Spring Forum Features Innovations in Patient-Centered Care from Global Leaders in Medically Integrated Oncology
April 23, 2025
NCODA will welcome leading oncology professionals to Denver as part of its International Spring Forum. Featured educational tracks include clinical, pharmacy technician, and nursing sessions along with workshops and roundtables for all attendees.
NCODA Announces Brand Updates, a New Website, and a Future of Innovation and Collaboration
April 13, 2025
As an organization, NCODA has always been committed to supporting our members in advancing the medically integrated healthcare team and advancing patient care. Today, we are excited to share some important changes that strengthen that commitment and reflect our evolution and focus. We have grown tremendously and are introducing meaningful updates to our brand and our online presence at ncoda.org.
NYOH Makes Capital Region History with the First Commercial CAR-T Cancer Treatment Locally
April 1, 2025
NCODA member practice, New York Oncology Hematology (NYOH), has achieved a significant milestone by administering the Capital Region’s first commercial CAR-T cell therapy on April 1, 2025, at their Cell Therapy Suite within Albany Medical Center.
NCODA Continues to Advocate for Revision of Stark Law to Ensure Access to Care for Oncology Patients: Virtual Town Hall Scheduled for August 24th
January 1, 2025
NCODA Continues to Advocate for Revision of Stark Law to Ensure Access to Care for Oncology Patients: Virtual Town Hall Scheduled for August 24th
NCODA International Abstract Published in Croatian Journal of Oncology
January 1, 2025
NCODA International Abstract Published in Croatian Journal of Oncology
BEYOND THE FIRST FILL
January 1, 2025
HOW 5 NCODA PRACTICES WERE EMPOWERED TO TAKE THE NEXT STEP IN IMPROVING PATIENT CARE